Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19
- 1 September 2021
- journal article
- review article
- Published by Taylor & Francis Ltd in Molecular and Cellular Biology
- Vol. 41 (9), e0018521
- https://doi.org/10.1128/mcb.00185-21
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-19 pandemic, responsible for millions of deaths globally. Even with effective vaccines, SARS-CoV-2 will likely maintain a hold in the human population through gaps in efficacy, percent vaccinated, and arising new strains. Therefore, understanding how SARS-CoV-2 causes widespread tissue damage and the development of targeted pharmacological treatments will be critical in fighting this virus and preparing for future outbreaks. Herein, we summarize the progress made thus far by using in vitro or in vivo models to investigate individual SARS-CoV-2 proteins and their pathogenic mechanisms. We have grouped the SARS-CoV-2 proteins into three categories: host entry, self-acting, and host interacting. This review focuses on the self-acting and host-interacting SARS-CoV-2 proteins and summarizes current knowledge on how these proteins promote virus replication and disrupt host systems, as well as drugs that target the virus and virus interacting host proteins. Encouragingly, many of these drugs are currently in clinical trials for the treatment of COVID-19. Future coronavirus outbreaks will most likely be caused by new virus strains that evade vaccine protection through mutations in entry proteins. Therefore, study of individual self-acting and host-interacting SARS-CoV-2 proteins for targeted therapeutic interventions is not only essential for fighting COVID-19 but also valuable against future coronavirus outbreaks.Keywords
Funding Information
- University of Maryland Baltimore Institute for Clinical and Translational Research (COVID-19 Accelerated Translational Incubator Pilot (ATIP))
This publication has 63 references indexed in Scilit:
- How HIV Nef Proteins Hijack Membrane Traffic To Promote InfectionJournal of Virology, 2019
- Mutations in ANKLE2, a ZIKA Virus Target, Disrupt an Asymmetric Cell Division Pathway in Drosophila Neuroblasts to Cause MicrocephalyDevelopmental Cell, 2019
- Alternative Experimental Models for Studying Influenza Proteins, Host–Virus Interactions and Anti-Influenza DrugsPharmaceuticals, 2019
- Inflammation-Induced, STING-Dependent Autophagy Restricts Zika Virus Infection in the Drosophila BrainCell Host & Microbe, 2018
- The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure StrategiesCurrent Pharmaceutical Design, 2017
- The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic InterventionInternational Journal of Molecular Sciences, 2017
- MERS-CoV papain-like protease has deISGylating and deubiquitinating activitiesVirology, 2013
- The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating ActivityJournal of Virology, 2005